Mirtazapine and Appetite disorder - a phase IV clinical study of FDA data

Summary:

Appetite disorder is reported as a side effect among people who take Mirtazapine (mirtazapine), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Morphine, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Appetite disorder when taking Mirtazapine. It is created by eHealthMe based on reports of 79,492 people who have side effects when taking Mirtazapine from the FDA, and is updated regularly.

What is Mirtazapine?

Mirtazapine has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 82,120 Mirtazapine users. Check the latest studies of Mirtazapine.

What is Appetite disorder?

Appetite disorder (abnormal eating habits) is found to be associated with 716 drugs and 707 conditions by eHealthMe. Check the latest studies of Appetite disorder.

On Jul, 18, 2026

79,492 people reported to have side effects when taking Mirtazapine.
Among them, 69 people (0.09%) have Appetite disorder.

Could Mirtazapine cause Appetite disorder?

Among these 69 people:

How long have people been on Mirtazapine when they have Appetite disorder? *

What is the gender of people who have Appetite disorder when taking Mirtazapine? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Appetite disorder when taking Mirtazapine? *

What are other drugs people take besides Mirtazapine? *

What are other side effects people have besides Appetite disorder? *

Tremor (trembling or shaking movements in one or more parts of your body): 25 people, 36.23%
Sleep Disorder: 18 people, 26.09%
Nausea (feeling of having an urge to vomit): 17 people, 24.64%
Weight Decreased: 16 people, 23.19%
Acute Kidney Failure: 15 people, 21.74%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 12 people, 17.39%
Weakness: 12 people, 17.39%
Bradypnea: 12 people, 17.39%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 12 people, 17.39%
Thymus Disorder (disease of thymus): 12 people, 17.39%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 7 people, 10.14%
Primary Myelofibrosis (primary disorder of the bone marrow): 6 people, 8.70%
Pain: 5 people, 7.25%
Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 5.80%
High Blood Cholesterol: 4 people, 5.80%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 5.80%
Sleep Disorder: 3 people, 4.35%
Indigestion: 3 people, 4.35%
Dyspnea (difficult or laboured breathing): 3 people, 4.35%
Constipation: 2 people, 2.90%

* Approximation only. Some reports may have incomplete information.

Do you take Mirtazapine and have Appetite disorder?

- Check whether Appetite disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mirtazapine:

Mirtazapine (82,120 reports)

Browse all side effects of Mirtazapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite disorder:

Appetite disorder (716 drugs)

Browse all the conditions that are associated with Appetite disorder:

Appetite disorder (707 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine (the active ingredients of Mirtazapine) and Mirtazapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.